Health
Nvidia's AI ambitions in medicine and health care are becoming clear
Nvidia CEO Jensen Huang delivers a keynote address during the Nvidia GTC Conference at the SAP Center in San Jose, California, on March 18, 2024. Justin Sullivan | Getty Images Last week, Nvidia announced deals with Johnson & Johnson for use of generative AI in surgery, and with GE Healthcare to improve medical imaging. The health […]
Read More
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images Amgen is taking a new approach as it tries to stand out in a crowded field of drugmakers racing to develop the next blockbuster weight loss drug. The biotech company is testing an injectable […]
Read More
Here's how much people are willing to spend on weight loss drugs, according to a new survey
Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Demand for weight loss drugs is booming in the U.S. despite their limited insurance coverage and roughly $1,000 monthly price tags before discounts. But some patients are willing to pay more out of […]
Read More
We're buying more of this health-care company amid an overdone sell-off
Shortly after the opening bell, we will be buying 140 shares of Abbott Laboratories at roughly $112. Following the trade, Jim Cramer’s Charitable Trust will own 700 shares of ABT, increasing our weighting in the portfolio to 2.42% from 1.95%. We are buying more Abbott Laboratories into its recent weakness as we continue to believe […]
Read More
FDA says safety issues with China-made syringes are 'more widespread' than previously known
Signage is seen outside the U.S. Food and Drug Administration headquarters in White Oak, Maryland, Aug. 29, 2020. Andrew Kelly | Reuters The U.S. Food and Drug Administration warned Tuesday that Chinese-made plastic syringes that are distributed in the U.S. have “more widespread” quality control issues than were previously known. In a safety communication, the […]
Read More
Nvidia stomps the bears. Plus, Cramer's thoughts on 2 struggling portfolio names
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Markets rebound as Nvidia goes green: […]
Read More
Jim Cramer defends Elon Musk's use of ketamine for depression: The CEO 'saved a lot of lives'
CNBC’s Jim Cramer said Tuesday that Elon Musk’s disclosure that he takes prescription ketamine for depression was courageous and “saved a lot of people from killing themselves.” “I defend him as much as possible because there are many people who would never be brave enough to admit they take this drug,” Cramer said on ” […]
Read More
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
3D Illustration of a human liver organ. magicmine | iStock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for […]
Read More
Disney gets a win in Nelson Peltz board fight. 2 other portfolio stocks mount comebacks
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Markets bounce : Stocks kicked off […]
Read More
Jim Cramer: It's not too late to buy this portfolio health-care stock after Friday's selloff
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. U.S. stocks jumped Monday as the Nasdaq and S & P 500 attempts to recover from back-to-back weekly losses. Major gains were seen in tech stocks to start the new […]
Read More